Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Controlled Pregabalin Trial In Fibromyalgia

ClinicalTrials.gov ID: NCT00230776

Public ClinicalTrials.gov record NCT00230776. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 12:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 14-Week, Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin Twice Daily In Patients With Fibromyalgia

Study identification

NCT ID
NCT00230776
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Industry
Enrollment
740 participants

Conditions and interventions

Conditions

Interventions

  • placebo Drug
  • pregabalin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2005
Primary completion
Not listed
Completion
Jun 30, 2006
Last update posted
Jan 25, 2021

2005 – 2006

United States locations

U.S. sites
89
U.S. states
30
U.S. cities
79
Facility City State ZIP Site status
Pfizer Investigational Site Little Rock Arkansas 72205
Pfizer Investigational Site Fresno California 93710
Pfizer Investigational Site La Jolla California 92037
Pfizer Investigational Site Northridge California 91325
Pfizer Investigational Site Pismo Beach California 93449
Pfizer Investigational Site Sacramento California 95825
Pfizer Investigational Site San Diego California 92103
Pfizer Investigational Site Walnut Creek California 94598
Pfizer Investigational Site Newark Delaware 19713
Pfizer Investigational Site DeLand Florida 32720
Pfizer Investigational Site Gainesville Florida 32610-0221
Pfizer Investigational Site Hollywood Florida 33023
Pfizer Investigational Site Melbourne Florida 32901
Pfizer Investigational Site Ocala Florida 34471
Pfizer Investigational Site Ocala Florida 34474
Pfizer Investigational Site Palm Beach Gardens Florida 33410
Pfizer Investigational Site Palm Harbor Florida 34684
Pfizer Investigational Site Sunrise Florida 33351
Pfizer Investigational Site Tampa Florida 33606
Pfizer Investigational Site Tampa Florida 33614
Pfizer Investigational Site West Palm Beach Florida 33407
Pfizer Investigational Site Gurnee Illinois 60031
Pfizer Investigational Site Moline Illinois 61265
Pfizer Investigational Site Morton Grove Illinois 60053
Pfizer Investigational Site Indianapolis Indiana 46202-5250
Pfizer Investigational Site Indianapolis Indiana 46250
Pfizer Investigational Site Dubuque Iowa 52001
Pfizer Investigational Site Dubuque Iowa 52002
Pfizer Investigational Site Prairie Village Kansas 66206
Pfizer Investigational Site Pratt Kansas 67124
Pfizer Investigational Site Lexington Kentucky 40509
Pfizer Investigational Site Kenner Louisiana 70065
Pfizer Investigational Site Metairie Louisiana 70006
Pfizer Investigational Site North Dartmouth Massachusetts 02747
Pfizer Investigational Site Watertown Massachusetts 02472
Pfizer Investigational Site Worcester Massachusetts 01610
Pfizer Investigational Site Lansing Michigan 48910
Pfizer Investigational Site Chaska Minnesota 55318
Pfizer Investigational Site Saint Paul Minnesota 55101
Pfizer Investigational Site Jefferson City Missouri 65109
Pfizer Investigational Site Kansas City Missouri 64106
Pfizer Investigational Site St Louis Missouri 63141
Pfizer Investigational Site Lincoln Nebraska 68516
Pfizer Investigational Site Morristown New Jersey 07960
Pfizer Investigational Site Albany New York 12205
Pfizer Investigational Site Endwell New York 13760
Pfizer Investigational Site New York New York 10022-1009
Pfizer Investigational Site West Seneca New York 14224
Pfizer Investigational Site Asheville North Carolina 28801
Pfizer Investigational Site Hickory North Carolina 28601
Pfizer Investigational Site Hickory North Carolina 28602
Pfizer Investigational Site Raleigh North Carolina 27609
Pfizer Investigational Site Salisbury North Carolina 28144
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Minot North Dakota 58701
Pfizer Investigational Site Cincinnati Ohio 45219
Pfizer Investigational Site Cincinnati Ohio 45227
Pfizer Investigational Site Cincinnati Ohio 45245
Pfizer Investigational Site Dayton Ohio 45402
Pfizer Investigational Site Toledo Ohio 43623
Pfizer Investigational Site Tulsa Oklahoma 74104-5428
Pfizer Investigational Site Allentown Pennsylvania 18103
Pfizer Investigational Site Bethlehem Pennsylvania 18015
Pfizer Investigational Site Norristown Pennsylvania 19401
Pfizer Investigational Site Pittsburgh Pennsylvania 15213
Pfizer Investigational Site Pittsburgh Pennsylvania 15218
Pfizer Investigational Site Goose Creek South Carolina 29445
Pfizer Investigational Site Mt. Pleasant South Carolina 29464
Pfizer Investigational Site Myrtle Beach South Carolina 29572
Pfizer Investigational Site Summerville South Carolina 29485
Pfizer Investigational Site Chattanooga Tennessee 37404
Pfizer Investigational Site Knoxville Tennessee 37909-1900
Pfizer Investigational Site Milan Tennessee 38358
Pfizer Investigational Site Nashville Tennessee 37203
Pfizer Investigational Site Bedford Texas 76021
Pfizer Investigational Site Georgetown Texas 78626
Pfizer Investigational Site Houston Texas 77030
Pfizer Investigational Site Killeen Texas 76549
Pfizer Investigational Site Lake Jackson Texas 77566
Pfizer Investigational Site San Antonio Texas 78213
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site Salt Lake City Utah 84102-1571
Pfizer Investigational Site Woodstock Vermont 05091
Pfizer Investigational Site Virginia Beach Virginia 23455
Pfizer Investigational Site Everett Washington 98201
Pfizer Investigational Site Spokane Washington 99204
Pfizer Investigational Site Spokane Washington 99216
Pfizer Investigational Site Tacoma Washington 98405
Pfizer Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00230776, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 25, 2021 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00230776 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →